Table 2 Combined analysis: 181 unique SORL1 variants in 1895 cases and 3206 controls

From: Characterization of pathogenic SORL1 genetic variants for association with Alzheimer’s disease: a clinical interpretation strategy

CADD score

N-variants in

burden test a

Cases

With at least

one variant

Total 1895

Controls

With at least

one variant

Total 3206

OR (95% CI)

P- value b (unadjusted))

ExAC-MAF >0.01 (each variant detected in >1200 subjects in the ExAC database)

 0–10

8c

1,895

3,206

1.0

1.0

 10–20

4c

1,895

3,206

1.0

1.0

 20–30

1

203

300

1.2 (1.0–1.4)

7.3 × 10−2

 >30

1

67

162

0.7 (0.5–0.9)

1.0

0.001< ExAC-MAF <0.01 (each variant detected in 121–1200 subjects in ExAC database)

 0–10

5c

93

158

1.0 (0.8–1.3)

0.52

 10–20

4c

68

151

0.8 (0.6–1.0)

0.98

 20–30

3

37

40

1.6 (1.0–2.5)

3.2 × 10−2

 >30

1

4

7

1.0 (0.3–3.3)

0.63

0.0001< ExAC-MAF <0.001 (each variant detected in 13–120 subjects in ExAC database)

 0–10

5

10

12

1.4 (0.6–3.3)

0.27

 10–20

5

9

11

1.4 (0.6–3.4)

0.30

 20–30

11

15

21

1.2 (0.6–2.4)

0.34

 >30

4

5

4

2.1 (0.6–7.9)

0.21

0.00001<ExAC-MAF <0.0001 (each variant detected in 2–12 subjects in ExAC database)

 0–10

5

7

10

1.2 (0.5–3.1)

0.45

 10–20

20

9

21

0.7 (0.3–1.6)

0.84

 20–30

22

9

23

0.7 (0.3–1.4)

0.90

 >30

9

10

2

8.5 (1.9–38.8)

1.4 × 10−3

ExAC-MAF <0.00001 (unknown or singletons in ExAC database)

 0–10

7

2

8

0.4 (0.1–2.0)

0.93

 10–20

15

9

7

2.2 (0.8–5.9)

9.4 × 10−2

 20–30

22

13

11

2.0 (0.9–4.5)

6.6 × 10−2

>30

29

28

4

12.0 (4.2–34.3)

5.0 × 109

  1. Variants were categorized according to the associated minor allele frequency reported in the ExAC database (ExAC-MAF) and CADD score.
  2. aIn the replication sample, we were not able to account for the overlap when one subject carried multiple variants with the same MAF.
  3. bAssociations that are significant after multiple testing correction are shown in bold (P<7.1 × 10−4).
  4. cFor common variants derived form the replication sample, the variant MAF reported in cases and controls was used to estimate the number of case-carriers and control-carriers.